International Registry Study of Neutral Lipid Storage Disease (NLSD) / Triglyceride Deposit Cardiomyovasculopathy (TGCV) and Related Diseases
Status: Unknown
Location: See all (15) locations...
Study Type: Observational
SUMMARY
This study aims to understand the state of onset of NLSD(neutral lipid storage disease) / TGCV(triglyceride deposit cardiovasculopathy) worldwide, background information of affected patients, and natural history of the disease, as well as exploring the prognostic factors and assessing the efficacy of disease-specific treatment.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• Patients who are diagnosed with NLSD / TGCV
Locations
United States
California
Stanford University
RECRUITING
Stanford
New York
Columbia University
RECRUITING
New York
Other Locations
Austria
University of Graz
RECRUITING
Graz
China
Peking University First Hospital
RECRUITING
Beijing
France
Pitié-Salpêtrière Hospital
RECRUITING
Paris
Germany
Ludwig-Maximilians University
RECRUITING
Munich
Italy
Catholic University
RECRUITING
Milan
University of Padova
RECRUITING
Padua
A.C.O. San Filippo Neri Hospital
RECRUITING
Rome
Sapienza University of Rome
RECRUITING
Rome
Japan
National Center of Neurology and Psychiatry
RECRUITING
Kodaira
Graduate School of Osaka University
RECRUITING
Suita
Netherlands
Maastricht University
RECRUITING
Maastricht
United Kingdom
Harefield Hospital
RECRUITING
Harefield
New Castle University
RECRUITING
Newcastle Upon Tyne
Contact Information
Primary
Kenichi Hirano, MD, Ph.D
+81-6-6872-8215
Time Frame
Start Date: 2014-01
Completion Date: 2025-03
Participants
Target number of participants: 120
Treatments
NLSD / TGCV
Patients who are diagnosed with NLSD / TGCV
Sponsors
Leads: Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan